Adherence, safety, and choice of the monthly dapivirine vaginal ring or oral emtricitabine plus tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis among African adolescent girls and young women: a randomised, open-label, crossover trial
Gonasagrie Nair, Kenneth Ngure(University of Nairobi), Felix Muhlanga(University of Zimbabwe), Pippa Macdonald(Desmond Tutu HIV Foundation), Cindy Jacobson(University of Pittsburgh), Bekezela Siziba(University of Zimbabwe), Sharon L. Hillier(Magee-Womens Research Institute), Sherri Johnson(Family Health International 360), Tara McClure(Family Health International 360), Sybil Hosek(University of Illinois Chicago), John Steytler, Linda‐Gail Bekker(Desmond Tutu HIV Foundation), Krishnaveni Reddy(Perinatal HIV Research Unit), James F. Rooney(Gilead Sciences (United States)), Craig W. Hendrix(Unknown), Peter L. Anderson(University of Colorado Denver), Jared M. Baeten(University of Washington), Eunice Tahuringana(University of Zimbabwe), Thesla Palanee‐Phillips(University of the Witwatersrand), Edward Livant(University of Pittsburgh), Ariane van der Straten(University of California, San Francisco), Carolyne A. Akello, Morgan Garcia(Family Health International 360), Urvi M. Parikh(University of Pittsburgh), Rita Nakalega(MUJHU Research Collaboration), Connie Celum(University of Washington), Elizabeth R. Brown(Fred Hutch Cancer Center), Lydia Soto-Torres, Daniel Szydlo(University of Washington), Gakiema Milan(Desmond Tutu HIV Foundation), Katherine Bunge(Fred Hutch Cancer Center), Clemensia Nakabiito(Makerere University), Lisa Levy(Fred Hutch Cancer Center)
Cited by 62
Related Papers
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
|New England Journal of Medicine|2012|3.3k
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
|The Lancet|1999|1.7k
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection
|New England Journal of Medicine|2015|1.6k
Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis
|The Lancet|2010|958
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
|New England Journal of Medicine|2021|891